Terms: = Colorectal cancer AND BCL7A, BCL7, 605, ENSG00000110987 AND Treatment
28 results:
1. Polypharmacy and potentially-inappropriate medications are prevalent in the elderly cancer patients receiving systemic cancer therapy and they co-relate with adverse outcomes.
Bandidwattanawong C; Rattanaserikulchai P; Jetsadavanit N
BMC Geriatr; 2023 Nov; 23(1):775. PubMed ID: 38012569
[TBL] [Abstract] [Full Text] [Related]
2. Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of cancers During Chemoradiation Therapy: Real-World Study.
Kang D; Kim S; Kim H; Lee M; Kong SY; Chang YJ; Sim SH; Kim YJ; Cho J
JMIR Public Health Surveill; 2023 Mar; 9():e44105. PubMed ID: 36884274
[TBL] [Abstract] [Full Text] [Related]
3. [Efficacy of endoscopic treatment oncolorectal laterally spreading tumor and risk factors of delayed bleeding after operation].
Yu QY; Xue M; Wang LJ
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(46):3680-3685. PubMed ID: 36509539
[No Abstract] [Full Text] [Related]
4. Morbidity and long-term results in patients with wild and mutant type Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations undergoing colorectal cancer surgery.
Aziret M; Subasi O; Bilir C; Tozlu M; Altıntoprak F; Karaman K; Ercan M; Celebi F
Ann Ital Chir; 2022; 92():65-77. PubMed ID: 35342104
[TBL] [Abstract] [Full Text] [Related]
5. Early detection of treatment futility in patients with metastatic colorectal cancer.
Rattner JI; Kopciuk KA; Vogel HJ; Tang PA; Shapiro JD; Tu D; Jonker DJ; Siu LL; O'Callaghan CJ; Bathe OF
Oncotarget; 2022; 13():61-72. PubMed ID: 35028011
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German cancer Consortium-Radiation Oncology Group (DKTK-ROG).
Martin D; Schreckenbach T; Ziegler P; Filmann N; Kalinauskaite G; Tinhofer I; Budach V; Gani C; Zips D; Schimek-Jasch T; Schäfer H; Grosu AL; Thomas E; Krause M; Dapper H; Combs S; Hoffmann C; Stuschke M; Walter F; Belka C; Kurth I; Hadiwikarta WW; Baumann M; Rödel C; Fokas E
Radiother Oncol; 2022 Feb; 167():233-238. PubMed ID: 34999135
[TBL] [Abstract] [Full Text] [Related]
7. Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study.
Yamashita R; Long J; Longacre T; Peng L; Berry G; Martin B; Higgins J; Rubin DL; Shen J
Lancet Oncol; 2021 Jan; 22(1):132-141. PubMed ID: 33387492
[TBL] [Abstract] [Full Text] [Related]
8. Differences in Stage of cancer at Diagnosis, treatment, and Survival by Race and Ethnicity Among Leading cancer Types.
Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
[TBL] [Abstract] [Full Text] [Related]
9. LncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis in gastric cancer by targeting miR-605-3p.
Su YZ; Cui MF; Du J; Song B
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1158-1167. PubMed ID: 32096164
[TBL] [Abstract] [Full Text] [Related]
10. Effectiveness of 23-valent pneumococcal polysaccharide vaccine on elderly patients with colorectal cancer: A population-based propensity score-matched cohort study.
Chiou WY; Hung SK; Lin HY; Chen LC; Hsu FC; Tsai SJ; Yu BH; Lee MS; Li CY
Medicine (Baltimore); 2019 Dec; 98(50):e18380. PubMed ID: 31852152
[TBL] [Abstract] [Full Text] [Related]
11. Colonoscopy in Nonagenarians Is Safe and May Be Associated with Clinical Benefit.
Shafrir A; Koslowsky B; Wengrower D; Goldin E; Livovsky DM
J Am Geriatr Soc; 2019 Jun; 67(6):1158-1163. PubMed ID: 30801669
[TBL] [Abstract] [Full Text] [Related]
12. Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours.
Martin V; Chiriaco C; Modica C; Acquadro A; Cortese M; Galimi F; Perera T; Gammaitoni L; Aglietta M; Comoglio PM; Vigna E; Sangiolo D
Br J Cancer; 2019 Mar; 120(5):527-536. PubMed ID: 30723303
[TBL] [Abstract] [Full Text] [Related]
13. Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.
GabAllah GMK; El-Din Habib MS; Soliman SE; Kasemy ZA; Gohar SF
Saudi J Gastroenterol; 2017; 23(6):348-356. PubMed ID: 29205188
[TBL] [Abstract] [Full Text] [Related]
14. Complete mesocolic excision an assessment of feasibility and outcome.
Bertelsen CA
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157065
[TBL] [Abstract] [Full Text] [Related]
15. Indeterminate but Likely Unimportant Extracolonic Findings at Screening CT Colonography (C-RADS Category E3): Incidence and Outcomes Data From a Clinical Screening Program.
Pooler BD; Kim DH; Pickhardt PJ
AJR Am J Roentgenol; 2016 Nov; 207(5):996-1001. PubMed ID: 27505184
[TBL] [Abstract] [Full Text] [Related]
16. Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes.
McCann KJ; Mander A; Cazaly A; Chudley L; Stasakova J; Thirdborough S; King A; Lloyd-Evans P; Buxton E; Edwards C; Halford S; Bateman A; O'Callaghan A; Clive S; Anthoney A; Jodrell DI; Weinschenk T; Simon P; Sahin U; Thomas GJ; Stevenson FK; Ottensmeier CH
Clin Cancer Res; 2016 Oct; 22(19):4827-4836. PubMed ID: 27091407
[TBL] [Abstract] [Full Text] [Related]
17. Surgical management of rectal carcinoids: trends and outcomes from the Surveillance, Epidemiology, and End Results database (1988 to 2012).
McConnell YJ
Am J Surg; 2016 May; 211(5):877-85. PubMed ID: 27048945
[TBL] [Abstract] [Full Text] [Related]
18. Expression of Human Epidermal Growth Factor Receptor-2 in Resected Rectal cancer.
Meng X; Huang Z; Di J; Mu D; Wang Y; Zhao X; Zhao H; Zhu W; Li X; Kong L; Xing L
Medicine (Baltimore); 2015 Nov; 94(47):e2106. PubMed ID: 26632727
[TBL] [Abstract] [Full Text] [Related]
19. Iron therapy for the treatment of preoperative anaemia in patients with colorectal carcinoma: a systematic review.
Borstlap WA; Stellingwerf ME; Moolla Z; Musters GD; Buskens CJ; Tanis PJ; Bemelman WA
Colorectal Dis; 2015 Dec; 17(12):1044-54. PubMed ID: 26342151
[TBL] [Abstract] [Full Text] [Related]
20. Analyzing proteasomal subunit expression reveals Rpt4 as a prognostic marker in stage II colorectal cancer.
McCawley N; Conlon S; Hector S; Cummins RJ; Dicker P; Johnston PG; Kay EW; McNamara DA; Prehn JH; Concannon CG
Int J Cancer; 2012 Aug; 131(4):E494-500. PubMed ID: 21960357
[TBL] [Abstract] [Full Text] [Related]
[Next]
